|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 733.04 USD | -1.20% |
|
-7.97% | -5.03% |
| 16/01 | Where the Money's Moving |  |
| 16/01 | Bayer's Eylea Secures EU Approval for Retinal Vein Occlusion | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.52TCr | |||||
| 6.12TCr | |||||
| 5.85TCr | |||||
| 5.65TCr | |||||
| 2.41TCr | |||||
| 2.09TCr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition